As of 4:00pm ET
| +0.08 / +0.48%|
The 6 analysts offering 12-month price forecasts for Insmed Inc have a median target of 22.00, with a high estimate of 35.00 and a low estimate of 14.00. The median estimate represents a +31.19% increase from the last price of 16.77.
The current consensus among 7 polled investment analysts is to Buy stock in Insmed Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.